Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.6B |
| 2 |
Broadcom
AVGO
|
+$1.11B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$882M |
| 4 |
JPMorgan Chase
JPM
|
+$628M |
| 5 |
Tesla
TSLA
|
+$594M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$1.54B |
| 2 |
Visa
V
|
+$1.39B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.13B |
| 4 |
Amazon
AMZN
|
+$771M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$575M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 45.6% |
| 2 | Technology | 19.83% |
| 3 | Financials | 7.37% |
| 4 | Consumer Discretionary | 6.6% |
| 5 | Communication Services | 5.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4251
AllianzIM U.S. Equity Buffer10 Dec ETF
DECT
$127M
| $178K | ﹤0.01% |
5,321
-1,061
| -17% | -$33.4K |
2025 Q1
1 quarter
|
|
4252
Establishment Labs
ESTA
$1.91B
| $178K | ﹤0.01% |
4,159
-39
| -0.9% | -$1.36K |
2023 Q2
8 quarters
|
|
|
LAR
4253
Lithium Argentina AG
LAR
$901M
| $178K | ﹤0.01% |
85,391
-12,991
| -13% | -$25.9K |
2023 Q4
6 quarters
|
|
4254
Finward Bancorp
FNWD
$184M
| $177K | ﹤0.01% |
6,395
+6,376
| +33,558% | +$188K |
2024 Q3
3 quarters
|
|
4255
Inseego
INSG
$81.1M
| $177K | ﹤0.01% |
21,422
+10,335
| +93% | +$80.8K |
2017 Q4
30 quarters
|
|
4256
Gyre Therapeutics
GYRE
$754M
| $176K | ﹤0.01% |
24,004
+15,553
| +184% | +$136K |
2024 Q2
4 quarters
|
|
4257
Clarus
CLAR
$132M
| $176K | ﹤0.01% |
50,801
+19,986
| +65% | +$67.7K |
2016 Q1
37 quarters
|
|
4258
Global X S&P 500 Quality Dividend ETF
QDIV
$28.7M
| $176K | ﹤0.01% |
5,200
| – | – |
2024 Q4
2 quarters
|
|
|
ILLR
4259
Triller Group Inc
ILLR
$5.07M
| $176K | ﹤0.01% |
+18,894
| New | +$167K |
2025 Q2
0 quarters
|
|
4260
CALL
Regenxbio
RGNX
$490M
| $176K | ﹤0.01% |
21,400
| – | – |
2025 Q1
1 quarter
|
|
|
4261
PUT
Regenxbio
RGNX
$490M
| $176K | ﹤0.01% |
21,400
| – | – |
2025 Q1
1 quarter
|
|
4262
Ascent Industries
ACNT
$124M
| $175K | ﹤0.01% |
13,917
+13,807
| +12,552% | +$176K |
2024 Q4
2 quarters
|
|
4263
FT Vest US Equity Max Buffer ETF March
MARM
$106M
| $175K | ﹤0.01% |
5,461
+749
| +16% | +$23.6K |
2024 Q3
3 quarters
|
|
|
CANG
4264
Cango Inc
CANG
$110M
| $175K | ﹤0.01% |
3,606
| – | – |
2025 Q1
1 quarter
|
|
4265
Vanguard Morningstar Mega Cap Growth ETF
MGK
$34.9B
| $175K | ﹤0.01% |
2,385
-66,760
| -97% | -$4.4M |
2023 Q2
8 quarters
|
|
|
EH
4266
EHang Holdings
EH
$314M
| $174K | ﹤0.01% |
10,040
-1,360
| -12% | -$23.1K |
2024 Q4
2 quarters
|
|
4267
PUT
Teladoc Health
TDOC
$1B
| $174K | ﹤0.01% |
20,000
| – | – |
2025 Q1
1 quarter
|
|
|
GENVR
4268
Gen Digital Inc Contingent Value Rights
GENVR
| $173K | ﹤0.01% |
+21,606
| New | +$152K |
2025 Q2
0 quarters
|
|
4269
Nuvectis Pharma
NVCT
$716M
| $173K | ﹤0.01% |
23,174
+22,015
| +1,899% | +$200K |
2023 Q2
8 quarters
|
|
4270
AudioEye
AEYE
$87M
| $173K | ﹤0.01% |
14,854
+4,913
| +49% | +$58.6K |
2024 Q2
4 quarters
|
|
4271
Finance of America Companies
FOA
$124M
| $173K | ﹤0.01% |
7,411
-10,109
| -58% | -$213K |
2024 Q4
2 quarters
|
|
4272
iShares MSCI USA Momentum Factor ETF
MTUM
$21.3B
| $172K | ﹤0.01% |
717
-1,562
| -69% | -$341K |
2023 Q1
9 quarters
|
|
4273
iShares MSCI Taiwan ETF
EWT
$12.7B
| $171K | ﹤0.01% |
2,985
+1,999
| +203% | +$102K |
2024 Q4
2 quarters
|
|
4274
CVRx
CVRX
$41.3M
| $170K | ﹤0.01% |
28,877
+12,319
| +74% | +$85K |
2023 Q1
9 quarters
|
|
4275
NI Holdings
NODK
$306M
| $170K | ﹤0.01% |
13,316
+3,695
| +38% | +$47.8K |
2017 Q2
32 quarters
|
|
Similar funds
Barclays's Q2 2025 Portfolio in Review
As of Q2 2025, Barclays held 5,681 positions worth $436B, up 24% from $353B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Barclays's Q2 2025 filing shows 461 new, 2,914 increased, 1,345 reduced and 463 closed positions. Its largest new stake was iShares MBS ETF: 4,310,047 shares worth $405M. The largest sale was Honeywell, an estimated $1.54B.
By sector, the portfolio is most concentrated in Miscellaneous at 46% of assets, up from 41% a quarter earlier, followed by Technology and Financials.
- Barclays's largest Q2 2025 buy was iShares MBS ETF: 4,310,047 shares worth $405M.
- Barclays added most to NVIDIA in Q2 2025, an estimated $1.6B increase.
- Barclays's biggest Q2 2025 reduction was Honeywell, cutting an estimated $1.54B.
- Barclays fully exited Berry Global Group, Inc. in Q2 2025, selling an estimated $173M.
- Barclays's ten largest holdings make up 43% of its $436B portfolio in Q2 2025.
- Barclays opened 461 new positions and closed 463 in Q2 2025.
- Barclays's portfolio value rose 24% quarter-over-quarter to $436B.
Based on Barclays's 13F filing for Q2 2025, filed 13 Aug 2025.